BIOMARIN PHARMACEUTICAL INC — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| BIENAIME JEAN JACQUES | Chief Executive Officer | Sale | 10,000 | $21.00 | $210,000 | 6,695 | Aug 17, 2007 |
| Davis George Eric | VP, General Counsel | Sale | 4,000 | $20.26 | $81,040 | 2,607 | Aug 15, 2007 |
| ASELAGE STEVE | SVP, Global Commercial Dev | Sale | 300 | $20.22 | $6,066 | 24,595 | Aug 10, 2007 |
| BIENAIME JEAN JACQUES | Chief Executive Officer | Sale | 2,000 | $20.21 | $40,420 | 6,695 | Aug 10, 2007 |
| LEWIS ALAN | — | Option Exercise | 30,000 | $7.72 | $231,600 | 30,000 | Aug 10, 2007 |
| Wood Mark | VP, Human Resources | Option Exercise | 1,049 | $11.74 | $12,315 | 1,049 | Aug 10, 2007 |
| Cooper Jeffrey H | SVP, Chief Financial Officer | Sale | 12,500 | $21.00 | $262,500 | — | Aug 8, 2007 |
| BIENAIME JEAN JACQUES | Chief Executive Officer | Sale | 100 | $18.00 | $1,800 | 7,595 | Aug 3, 2007 |
| BIENAIME JEAN JACQUES | Chief Executive Officer | Sale | 1,000 | $18.31 | $18,310 | 9,695 | Jul 5, 2007 |
| Swiedler Stuart J | SVP, Clinical Affairs | Sale | 200 | $18.19 | $3,638 | 13,750 | Jul 2, 2007 |
| BIENAIME JEAN JACQUES | Chief Executive Officer | Sale | 2,500 | $17.65 | $44,125 | 10,695 | Jun 25, 2007 |
| Wood Mark | VP, Human Resources | Option Exercise | 514 | $6.37 | $3,274 | 514 | Jun 7, 2007 |
| BIENAIME JEAN JACQUES | Chief Executive Officer | Sale | 900 | $18.37 | $16,533 | 18,695 | Jun 1, 2007 |
| BIENAIME JEAN JACQUES | Chief Executive Officer | Sale | 100 | $18.58 | $1,858 | 17,595 | May 21, 2007 |
| BIENAIME JEAN JACQUES | Chief Executive Officer | Sale | 100 | $16.70 | $1,670 | 32,595 | May 3, 2007 |
| BIENAIME JEAN JACQUES | Chief Executive Officer | Sale | 500 | $16.44 | $8,220 | 15,642 | May 2, 2007 |
| ASELAGE STEVE | SVP, Global Commercial Dev | Purchase | 2,066 | $6.92 | $14,297 | 4,895 | Apr 30, 2007 |
| BAFFI ROBERT | SVP, Technical Operations | Purchase | 2,684 | $5.19 | $13,930 | 33,124 | Apr 30, 2007 |
| Davis George Eric | VP, General Counsel | Purchase | 2,607 | $5.19 | $13,530 | 2,607 | Apr 30, 2007 |
| KAKKIS EMIL D | Chief Medical Officer | Purchase | 2,982 | $5.19 | $15,477 | 94,126 | Apr 30, 2007 |
| BIENAIME JEAN JACQUES | Chief Executive Officer | Sale | 400 | $17.95 | $7,180 | 18,642 | Apr 4, 2007 |
| Swiedler Stuart J | SVP, Clinical Affairs | Sale | 1,500 | $17.29 | $25,935 | 15,000 | Apr 2, 2007 |
| KLEIN JOSEPH III | — | Sale | 800 | $16.39 | $13,112 | — | Mar 7, 2007 |
| BIENAIME JEAN JACQUES | Chief Executive Officer | Sale | 500 | $16.56 | $8,280 | 19,142 | Mar 2, 2007 |
| Davis George Eric | VP, General Counsel | Sale | 2,284 | $18.39 | $42,003 | 10,716 | Feb 22, 2007 |
| BIENAIME JEAN JACQUES | Chief Executive Officer | Sale | 1,000 | $18.40 | $18,400 | 19,642 | Feb 20, 2007 |
| ASELAGE STEVE | SVP, Global Commercial Ops | Sale | 15,000 | $20.00 | $300,000 | 2,829 | Feb 14, 2007 |
| Swiedler Stuart J | SVP, Clinical Affairs | Sale | 12,500 | $16.30 | $203,750 | 10,000 | Jan 3, 2007 |
| LAPALME PIERRE | — | Purchase | 1,000 | $17.88 | $17,880 | 6,600 | Dec 12, 2006 |
| LAPALME PIERRE | — | Purchase | 1,000 | $17.88 | $17,880 | 5,500 | Dec 12, 2006 |
| Cooper Jeffrey H | Chief Financial Officer | Sale | 14,500 | $18.00 | $261,000 | — | Dec 6, 2006 |
| ASELAGE STEVE | SVP, Global Commercial Ops | Option Exercise | 5,000 | $7.16 | $35,800 | 7,829 | Nov 29, 2006 |
| Swiedler Stuart J | SVP, Clinical Affairs | Sale | 12,500 | $15.92 | $199,000 | 10,000 | Nov 1, 2006 |
| BAFFI ROBERT | SVP, Technical Operations | Purchase | 3,894 | $3.43 | $13,356 | 30,440 | Oct 31, 2006 |
| BIENAIME JEAN JACQUES | Chief Executive Officer | Purchase | 2,761 | $6.92 | $19,106 | 33,642 | Oct 31, 2006 |
| ASELAGE STEVE | SVP, Global Commercial Ops | Purchase | 1,870 | $6.92 | $12,940 | 2,829 | Oct 31, 2006 |
| KAKKIS EMIL D | Chief Medical Officer | Purchase | 4,368 | $3.43 | $14,982 | 38,144 | Oct 31, 2006 |
| Cooper Jeffrey H | VP, Chief Financial Officer | Option Exercise | 6,000 | $6.13 | $36,780 | 26,000 | Aug 29, 2006 |
| KLEIN JOSEPH III | — | Option Exercise | 30,000 | $7.72 | $231,600 | 30,000 | Aug 9, 2006 |
| LAPALME PIERRE | — | Purchase | 1,000 | $15.35 | $15,350 | 4,500 | Aug 7, 2006 |
| Swiedler Stuart J | SVP, Clinical Affairs | Option Exercise | 12,500 | $4.00 | $50,000 | 22,500 | Aug 1, 2006 |
| BIENAIME JEAN JACQUES | Chief Executive Officer | Purchase | 1,500 | $14.50 | $21,750 | 30,881 | Aug 1, 2006 |
| HERON ELAINE J | — | Option Exercise | 20,000 | $4.72 | $94,400 | 20,000 | Jul 19, 2006 |
| BIENAIME JEAN JACQUES | Chief Executive Officer | Purchase | 500 | $14.44 | $7,220 | 29,381 | Jul 3, 2006 |
| BIENAIME JEAN JACQUES | Chief Executive Officer | Purchase | 500 | $13.20 | $6,600 | 27,381 | Jun 14, 2006 |
| BIENAIME JEAN JACQUES | Chief Executive Officer | Purchase | 1,500 | $13.05 | $19,575 | 25,381 | Jun 1, 2006 |
| BIENAIME JEAN JACQUES | Chief Executive Officer | Purchase | 1,000 | $12.00 | $12,000 | 23,881 | May 18, 2006 |
| BIENAIME JEAN JACQUES | Chief Executive Officer | Purchase | 1,000 | $12.78 | $12,780 | 22,881 | May 8, 2006 |
| BIENAIME JEAN JACQUES | Chief Executive Officer | Purchase | 500 | $12.56 | $6,280 | 18,500 | May 1, 2006 |
| KAKKIS EMIL D | Chief Medical Officer | Award / Grant | 4,202 | $3.43 | $14,413 | 33,776 | Apr 28, 2006 |